Short communication · 2020
Conference abstractPublished 8 Oct 2015
Newly developing drugs affecting apoptosis
Government Medical College Surat, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Apoptosis is the process of programmed cell death that occurs both physiologically as well as pathologically. It is a vital component in development of the embryo, hormone dependent atrophy, elimination of potentially harmful self-reactive lymphocytes, normal cell turnover and elimination of irreparably damaged cells. Inappropriate apoptosis (either too little or too much) is one of the causative factor in many human diseases. Defective apoptosis is involved in many cancers and autoimmune diseases. On the other hand, increased apoptosis is involved in neurodegenerative diseases, ischemic damage and death of virus infected cells. Currently, so much research is going on in the field of drugs affecting apoptosis so as to develop better drugs for above mentioned conditions. The goal of this poster is to provide the general overview on recent advances in this field. Some of the drugs included in this poster are: âÂ?¢ Oblimersen: It is a Bcl-2 antisense oligonucleotide. It reduces bcl-2 expression and sensitises cells to chemotherapy-induced apoptosis. It has potential to be used in chronic lymphocytic leukaemia (CLL), Melanoma and small cell and non-small cell lung cancer. âÂ?¢ IDN-6556: It is a potent inhibitor of caspases. It is being studied to see if it can improve liver function in cirrhosis with end stage liver disease. âÂ?¢ INO-1001: It is poly(ADP-ribose) polymerase (PARP) inhibitor. It has shown hemodynamic improvement in porcine myocardial ischemia and reperfusion.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 8 Sep 2014
Have FDA expedited programs really shortened drug review time? an analysis of newly approved therapies and how FDA expedited programs have impacted drug development timelines
Conference abstract · 2018
Maternal exposure to novel atypical psychotropic drugs: Impact on fetal brain development, apoptosis, neurodegeneration and psychopathological sequelae in young offspring
Conference abstract · 25 Aug 2015
Effects of newly synthesized indoline-2-thione derivatives on cell growth, apoptosis and MMP-9 expression of MCF-7 cells
Research article · 9 Feb 2023
Does the Assertiveness Skills Training Program Affect the Development of Sobering Behavior Among Drug Abusers? A Quasi- Experimental Study
More from this journal
The newest in Journal of Pharmaceutical Care & Health Systems.
Review article · 9 Jun 2025
Blood Fluid: The Unseen Currents That Bind Life and Death Together
Research article · 8 Jun 2025
Formulation and Antibacterial Evaluation of Acmella olaracea (Akarkara) Gummies Used for Toothache
Research article · 9 Apr 2025
Deep Vein Thrombosis: A Closer Look at a Silent Threat
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Care & Health Systems
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Vipul M Navadiya”

